Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardio Diagnostics Holdings (CDIO) Shares Outstanding (2021 - 2025)

Cardio Diagnostics Holdings' Shares Outstanding history spans 5 years, with the latest figure at $1.8 million for Q3 2025.

  • For Q3 2025, Shares Outstanding fell 94.18% year-over-year to $1.8 million; the TTM value through Sep 2025 reached $1.8 million, down 94.18%, while the annual FY2024 figure was $1.5 million, 123.68% up from the prior year.
  • Shares Outstanding for Q3 2025 was $1.8 million at Cardio Diagnostics Holdings, up from $1.7 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $13.1 million in Q3 2023 and bottomed at $684680.0 in Q4 2023.
  • The 5-year median for Shares Outstanding is $1.8 million (2025), against an average of $4.3 million.
  • The largest annual shift saw Shares Outstanding surged 587.9% in 2023 before it tumbled 94.18% in 2025.
  • A 5-year view of Shares Outstanding shows it stood at $4.2 million in 2021, then skyrocketed by 125.28% to $9.5 million in 2022, then crashed by 92.8% to $684680.0 in 2023, then soared by 123.68% to $1.5 million in 2024, then increased by 15.35% to $1.8 million in 2025.
  • Per Business Quant, the three most recent readings for CDIO's Shares Outstanding are $1.8 million (Q3 2025), $1.7 million (Q2 2025), and $1.7 million (Q1 2025).